about
The role of the serotonin receptor subtypes 5-HT1A and 5-HT7 and its interaction in emotional learning and memoryAn ancient duplication of exon 5 in the Snap25 gene is required for complex neuronal development/functionSpecific in vitro and in vivo binding of 3H-raclopride. A potent substituted benzamide drug with high affinity for dopamine D-2 receptors in the rat brainGalanin receptor antagonists : a potential novel pharmacological treatment for mood disordersEffects of antidepressant drugs on histamine-H1 receptors in the brainDifferential role of galanin receptors in the regulation of depression-like behavior and monoamine/stress-related genes at the cell body levelAntidepressant agents. 9. 3,3-Diphenylcyclobutylamines, a new class of central stimulantsGalanin, galanin receptor subtypes and depression-like behaviourProtection and repair of the nigrostriatal dopaminergic system by GDNF in vivoThe preparation and pharmacological properties of 3-acetyltyrosine and 3-acetyltyramineCentral 5-HT1A receptor-mediated modulation of heart rate dynamics and its adjustment by conditioned and unconditioned fear in mice.Analysis of the 5-HT1A receptor involvement in passive avoidance in the rat.Neural Stem Cell Transplant-Induced Effect on Neurogenesis and Cognition in Alzheimer Tg2576 Mice Is Inhibited by Concomitant Treatment with Amyloid-Lowering or Cholinergic α7 Nicotinic Receptor DrugsProlonged effects of intraventricular galanin on a 5-hydroxytryptamine(1A) receptor mediated function in the rat.Long distance signalling in volume transmission. Focus on clearance mechanisms.Substituted amphetamine derivatives. II. Behavioural effects in mice related to monoaminergic neurones.Substituted amphetamine derivatives. I. Effect on uptake and release of biogenic monoamines and on monoamine oxidase in the mouse brain.Adenosine receptors and Parkinson's disease. Relevance of antagonistic adenosine and dopamine receptor interactions in the striatum.Big dynorphin, a prodynorphin-derived peptide produces NMDA receptor-mediated effects on memory, anxiolytic-like and locomotor behavior in mice.Blockade of 5-HT 1B receptors facilitates contextual aversive learning in mice by disinhibition of cholinergic and glutamatergic neurotransmission.The role of 5-HT(1A) receptors in learning and memory.Differential effects of the neuropeptide galanin on striatal acetylcholine release in anaesthetized and awake ratsEnhanced hippocampal noradrenaline and serotonin release in galanin-overexpressing mice after repeated forced swimming test.Replacing SNAP-25b with SNAP-25a expression results in metabolic disease.Dopamine D1 receptor-mediated facilitation of GABAergic neurotransmission in the rat strioentopenduncular pathway and its modulation by adenosine A1 receptor-mediated mechanisms.The neuropeptide galanin as an in vivo modulator of brain 5-HT1A receptors: possible relevance for affective disorders.Upregulated dynorphin opioid peptides mediate alcohol-induced learning and memory impairment.Assessing aversive emotional states through the heart in mice: implications for cardiovascular dysregulation in affective disorders.Prenatal exposure to carbamazepine reduces hippocampal and cortical neuronal cell population in new-born and young mice without detectable effects on learning and memory.Nogo receptor 1 regulates formation of lasting memories.Neuropharmacological and behavioural properties of remoxipride in the rat.Neuropeptides in learning and memory processes with focus on galanin.Galanin, galanin receptor subtypes and depression-like behaviour.The possible involvement of GABA mechanisms in the action of benzodiazepines on central catecholamine neurons.Decreased 5-HT transporter mRNA in neurons of the dorsal raphe nucleus and behavioral depression in the obese leptin-deficient ob/ob mouse.Learning from the past and looking to the future: Emerging perspectives for improving the treatment of psychiatric disorders.Animal pharmacology of raclopride, a selective dopamine D2 antagonist.Selective monoamine oxidase inhibitors. 1. Compounds related to 4-aminophenethylamine.Synthesis and pharmacology of potentially neuroleptic derivatives of 3-chloro-spiro[5H-dibenzo[a,d]cycloheptene-5,1'-cyclohex-2'-en]-4'-amine.New selective dopamine D-2 antagonists as antipsychotic agents. Pharmacological, chemical, structural and theoretical considerations.
P50
Q26795511-E44E3F5A-AA75-451A-8A06-C26D4C720D29Q27313471-95E89254-E3B1-48B2-846E-69572B9BC1DAQ28235437-B236969B-BF9E-4D10-BED1-27564B638A3BQ28253725-F5F944B1-7E49-4E00-8F72-B960064D38D9Q28261367-3C4F6EC5-DD97-4632-A19F-B85607012BC6Q28263350-A7C4816C-93B4-48BD-8DAB-091ABE0B8292Q28270186-BF9B3954-151D-4344-B23A-0CA31F318851Q28281296-96066F9B-4D7C-4A18-8E37-B76D9C522DBAQ28306009-294B0AA2-0114-4081-BBE2-8E05A3DC1531Q28332182-F5F57ACD-8E08-4FDA-8B0C-FBEE722940A6Q30429534-1F684FAB-7C82-40B6-8477-8969F853378AQ30498714-09B6A198-B2DE-4933-B2CA-4E61BE7995A1Q30659307-A894236C-98B6-4091-BCD5-7C25A63B1256Q31888976-071B721B-FF03-4192-BA5A-EEB48562830AQ34093969-A53F49A9-6621-4126-9895-2FC53091191BQ34163242-156C3238-C90C-42C5-91B1-A0A69AF6F295Q34239659-E0EB9B98-6E5E-4E81-955D-497F6626A9FDQ34366891-3976AD4B-3786-4C9B-8E24-8BFF4BF3D1DEQ34468303-4BE12919-C924-4900-86B4-119CDCF79D05Q34768424-B22A394F-6352-4481-A139-85E06D012D0BQ34768436-BC2D9AFA-59E9-4293-8203-1F701CE940A3Q35026395-0D925E97-51E5-40FB-A651-34F759B6CB6FQ35122833-AF21871D-ED7B-4D41-8A15-F5685FE9AAEEQ35946184-18154649-8AB4-438F-BE1F-4200231354E9Q36813798-66E75539-1BA3-4CEF-85D1-FEC2FE774B47Q36856754-DD71187E-EC95-4B59-A484-79C13674E924Q37281169-27C1D0ED-D8F3-4E89-BF41-C9AADFB7E365Q37281818-A58048C7-9E57-4471-9227-F96E4DEC1E09Q37309361-6BCACB97-14D7-4317-9CBC-E5EE88F6A3A5Q37420622-03678233-96EF-492D-AA62-BF86D52D477FQ37604199-769C4505-ED38-44BF-B447-FB9315ACB0B2Q37616666-52CCDAE6-912A-4848-A4B0-EDDA2B69BD8DQ37836753-3E04B197-B3D4-4E95-9194-3424A658AA97Q38162033-A0DF3759-4551-4AB9-B88C-900C970B9769Q38308141-9B2B756D-DC8B-4ED6-9C86-89F8B59D16D9Q38402277-628BF916-9F54-4119-BC2A-9F8244F4D610Q38734073-F6782C0B-8134-4894-B74E-68F276A09A50Q39176455-6C8D846F-FFDD-4F3B-BE85-4FBD54103380Q39272264-03E19619-C926-49EE-88C0-CA36D0F26C1DQ39468634-187398FD-42DF-4774-BF50-3F70C1A9E142
P50
description
Zweeds onderzoeker
@nl
researcher ORCID ID = 0000-0003-2573-5276
@en
name
Sven Ove Ögren
@ast
Sven Ove Ögren
@en
Sven Ove Ögren
@es
Sven Ove Ögren
@nl
Sven Ove Ögren
@sl
type
label
Sven Ove Ögren
@ast
Sven Ove Ögren
@en
Sven Ove Ögren
@es
Sven Ove Ögren
@nl
Sven Ove Ögren
@sl
altLabel
S O Ogren
@en
prefLabel
Sven Ove Ögren
@ast
Sven Ove Ögren
@en
Sven Ove Ögren
@es
Sven Ove Ögren
@nl
Sven Ove Ögren
@sl
P106
P1153
7102994628
P21
P27
P31
P496
0000-0003-2573-5276